UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 113

Sortiert nach

Segmental arterial mediolysis and its mimickers: a case report and review of the literature

European journal of case reports in internal medicine, 2023-10, Vol.10 (11), p.004085-004085

2023

Link zum Volltext

Verfügbarkeit prüfen

Multicenter randomized‐controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo‐caecal resection

Inflammatory bowel diseases, 2007-02, Vol.13 (2), p.135-142

2007

Link zum Volltext

Verfügbarkeit prüfen

Viewpoint: Toward the Genetic Architecture of Disease Severity in Inflammatory Bowel Diseases

Inflammatory bowel diseases, 2018-06, Vol.24 (7), p.1428-1439

2018

Link zum Volltext

Verfügbarkeit prüfen

Switching biologics used in inflammatory bowel diseases: how to deal with in practice?

Current opinion in pharmacology, 2020-12, Vol.55, p.82-89

2020

Link zum Volltext

Verfügbarkeit prüfen

Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2019-10, Vol.157 (4), p.997-1006.e6

2019

Link zum Volltext

Verfügbarkeit prüfen

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs

Nature genetics, 2013-09, Vol.45 (9), p.984-994

2013

Link zum Volltext

Verfügbarkeit prüfen

Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta‐analysis of individual participant data

Hepatology (Baltimore, Md.), 2014-06, Vol.59 (6), p.2170-2177

2014

Link zum Volltext

Verfügbarkeit prüfen

Glucocorticoids and Inflammation Revisited: The State of the Art

Neuroimmunomodulation, 2002-01, Vol.10 (5), p.247-260

2002

Link zum Volltext

Verfügbarkeit prüfen

Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study

Inflammatory bowel diseases, 2024-01

2024

Link zum Volltext

Verfügbarkeit prüfen

Mo1558: REAL-WORLD EFFECTIVENESS AND SAFETY OF RISANKIZUMAB FOR MODERATE-SEVERE MULTI-REFRACTORY CROHN’S DISEASE: RESULTS FROM A BELGIAN MULTI-CENTRIC COHORT

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-818-S-819

2022

Link zum Volltext

Verfügbarkeit prüfen

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

Nature genetics, 2013-06, Vol.45 (6), p.670-675

2013

Link zum Volltext

Verfügbarkeit prüfen

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

Nature genetics, 2011-03, Vol.43 (3), p.246-52

2011

Link zum Volltext

Verfügbarkeit prüfen

Predictive models assessing the response to ustekinumab highlight the value of therapeutic drug monitoring in Crohn’s disease

Digestive and liver disease, 2023-03, Vol.55 (3), p.366-372

2023

Link zum Volltext

Verfügbarkeit prüfen

456 EFFICACY, SAFETY AND MUCOSAL HEALING OF EARLY VERSUS LATE USE OF VEDOLIZUMAB IN ULCERATIVE COLITIS: RESULTS FROM THE LOVE-UC STUDY

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-91-S-92

2021

Link zum Volltext

Verfügbarkeit prüfen

731 FAECAL MICROBIOTA TRANSPLANTATION IN ACTIVE ULCERATIVE COLITIS: INSIGHTS FROM A RANDOMIZED CONTROLLED TRIAL HALTED FOR FUTILITY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-176-S-177

2024

Link zum Volltext

Verfügbarkeit prüfen

Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology

PLoS genetics, 2011-01, Vol.7 (1), p.e1001273-e1001273

2011

Link zum Volltext

Verfügbarkeit prüfen

C‐reactive protein: Informative or misleading marker of Crohn's disease?

Inflammatory bowel diseases, 2007-04, Vol.13 (4), p.501-502

Franchimont, Denis

2007

Link zum Volltext

Verfügbarkeit prüfen

Mo1810 BASELINE RNA AND MICROBIOTA SIGNATURES ARE ASSOCIATED WITH RESPONSE AND GENERAL DECREASE IN BACTEROIDES-2 ENTEROTYPE AFTER FMT IN UC

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-919-S-920

2023

Link zum Volltext

Verfügbarkeit prüfen

Mo1816 NEOPLASTIC LESIONS OUTSIDE DISEASED AREA IN IBD PATIENTS: A NATIONAL COHORT STUDY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-935-S-935

2020

Link zum Volltext

Verfügbarkeit prüfen

Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis

Gut, 2023-11, Vol.72 (11), p.2068

2023

Link zum Volltext

Verfügbarkeit prüfen

440: STANDARDIZED FECAL MICROBIOTA TRANSPLANTATION THROUGH MICROBIOME-GUIDED DONOR SELECTION IN ACTIVE ULCERATIVE COLITIS PATIENTS: A RANDOMIZED, PLACEBO-CONTROLLED INTERVENTION STUDY

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-95-S-96

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 113

Suche als RSS-Feed

Aktive Filter

ThemaFemale

ThemaHuman Health Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(93)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Segmental arterial mediolysis and its mimickers: a case report and review of the literature

Multicenter randomized‐controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo‐caecal resection

Viewpoint: Toward the Genetic Architecture of Disease Severity in Inflammatory Bowel Diseases

Switching biologics used in inflammatory bowel diseases: how to deal with in practice?

Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations

Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s Disease

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs

Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta‐analysis of individual participant data

Glucocorticoids and Inflammation Revisited: The State of the Art

Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC)

Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study

Mo1558: REAL-WORLD EFFECTIVENESS AND SAFETY OF RISANKIZUMAB FOR MODERATE-SEVERE MULTI-REFRACTORY CROHN’S DISEASE: RESULTS FROM A BELGIAN MULTI-CENTRIC COHORT

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

Predictive models assessing the response to ustekinumab highlight the value of therapeutic drug monitoring in Crohn’s disease

456 EFFICACY, SAFETY AND MUCOSAL HEALING OF EARLY VERSUS LATE USE OF VEDOLIZUMAB IN ULCERATIVE COLITIS: RESULTS FROM THE LOVE-UC STUDY

731 FAECAL MICROBIOTA TRANSPLANTATION IN ACTIVE ULCERATIVE COLITIS: INSIGHTS FROM A RANDOMIZED CONTROLLED TRIAL HALTED FOR FUTILITY

Rigorous Donor Selection for Fecal Microbiota Transplantation in Active Ulcerative Colitis: Key Lessons From a Randomized Controlled Trial Halted for Futility

Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology

C‐reactive protein: Informative or misleading marker of Crohn's disease?

Mo1810 BASELINE RNA AND MICROBIOTA SIGNATURES ARE ASSOCIATED WITH RESPONSE AND GENERAL DECREASE IN BACTEROIDES-2 ENTEROTYPE AFTER FMT IN UC

Mo1816 NEOPLASTIC LESIONS OUTSIDE DISEASED AREA IN IBD PATIENTS: A NATIONAL COHORT STUDY

Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis

Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis

440: STANDARDIZED FECAL MICROBIOTA TRANSPLANTATION THROUGH MICROBIOME-GUIDED DONOR SELECTION IN ACTIVE ULCERATIVE COLITIS PATIENTS: A RANDOMIZED, PLACEBO-CONTROLLED INTERVENTION STUDY

Aktive Filter

Suchergebnisse filtern